Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for The Harvard Drug Group, LLC dba Major Pharmaceutical and Rugby Laboratories.
Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.
The Harvard Drug Group, LLC dba Major Pharmaceutical and Rugby Laboratories: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.
Side by side
Philips North America — Warning letters0
The Harvard Drug Group, LLC dba Major Pharmaceutical and Rugby Laboratories — Warning letters0
Philips North America — Recalls355
The Harvard Drug Group, LLC dba Major Pharmaceutical and Rugby Laboratories — Recalls0
Philips North America — Approval records0
The Harvard Drug Group, LLC dba Major Pharmaceutical and Rugby Laboratories — Approval records0
Philips North America — Form 483s0
The Harvard Drug Group, LLC dba Major Pharmaceutical and Rugby Laboratories — Form 483s1
Timeline
The Harvard Drug Group, LLC dba Major Pharmaceutical and Rugby Laboratories
Most recent FDA action: March 20, 2026
Full history →Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Philips North America vs The Harvard Drug Group, LLC dba Major Pharmaceutical and Rugby Laboratories: FDA Enforcement Comparison." Argus HQ, accessed August 17, 2026. https://argushq.ai/compare/philips-north-america-vs-the-harvard-drug-group-llc-dba-major-pharmaceutical-and-rugby-laboratories
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗